Skip to main content
SpringerLink
Log in

Associations of serum uric acid and gamma-glutamyltransferase with cancer in the Vorarlberg Health Monitoring and Promotion Programme (VHM&PP) – a short review

  • Short review
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Summary

The Vorarlberg Health Monitoring and Promotion Programme (VHM&PP), based on prospectively gathered, repeated routine health examination data from a cohort of more than 175,000 adults, is one of the largest ongoing population-based risk factor surveillance programmes worldwide. Among others, the so far widely unknown associations of serum uric acid (SUA) and gamma-glutamyltransferase (GGT) with cancer were investigated. Both SUA and GGT are known to be related to the metabolic syndrome and furthermore considered as markers of oxidative stress. After controlling for several confounding factors, it was found that elevated SUA levels were statistically significantly related to overall cancer mortality and several site-specific malignancies in both men and women. Additionally, a J-shaped effect of SUA levels on risk of overall cancer incidence appeared in men, with significantly increased cancer risk at high levels of SUA. Likewise, in accordance with some experimental evidence, among men and women elevated GGT increased cancer risk overall and for several lifestyle-related malignancies. On the basis of these findings, and considering the routine measurement in clinical practice, SUA and GGT might function as a valuable marker to identify patients with an increased risk to develop malignant diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Beard JT. Serum uric acid and coronary heart disease. Am Heart J, 106: 397–400, 1983

    Article  PubMed  Google Scholar 

  • Koenig W, Meisinger C. Urid acid, type 2 diabetes, and cardiovascular diseases: fueling the common soil hypothesis? Clin Chem, 54: 231–233, 2008

    Article  PubMed  CAS  Google Scholar 

  • Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health, 4: 9, 2004

    Article  PubMed  CAS  Google Scholar 

  • Ames BN, Cathcart R, Schweirs E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A, 78: 6858–6862, 1981

    Article  PubMed  CAS  Google Scholar 

  • Hiatt RA, Fireman BH. Serum uric acid unrelated to cancer incidence in humans. Cancer Res, 48: 2916–2918, 1988

    PubMed  CAS  Google Scholar 

  • Kolonel LN, Yoshizawa C, Nomura AM, Stemmermann GN. Relationship of serum uric acid to cancer occurrence in a prospective male cohort. Cancer Epidemiol Biomarkers Prev, 3: 225–228, 1994

    PubMed  CAS  Google Scholar 

  • Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci, 38: 263–355, 2001

    Article  PubMed  CAS  Google Scholar 

  • Lee DH, Ha MH, Kam S, Chun B, Lee J, Song K, Boo Y, Steffen L, Jacobs DR Jr. A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men. Am J Epidemiol, 163: 57–65, 2006

    Article  PubMed  Google Scholar 

  • Pompella A, Emdin M, Passino C, Paolicchi A. The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med, 42: 1085–1091, 2004

    Article  PubMed  CAS  Google Scholar 

  • Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham heart study. Arterioscler Thromb Vasc Biol, 27: 127–133, 2007

    Article  PubMed  CAS  Google Scholar 

  • Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. The Vorarlberg health monitoring and promotion programme study group. γ-Glutamyltransferase as a risk factor for cardiovascular disease mortality, an epidemiological investigation in a cohort of 163 944 Austrian adults. Circulation, 112: 2130–2137, 2005

    Article  PubMed  CAS  Google Scholar 

  • Pompella A, De Tata V, Paolicchi A, Zunino F. Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance. Biochem Pharmacol, 71: 231–238, 2006

    Article  PubMed  CAS  Google Scholar 

  • Lee DH, Jacobs DR Jr. Association between serum concentrations of persistent organic pollutants and glutamyltransferase: results from the National Health and Examination Survey 1999–2002. Clin Chem, 52: 1825–1827, 2006

    Article  PubMed  CAS  Google Scholar 

  • Ulmer H, Kelleher C, Diem G, Concin H. Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: the Vorarlberg Health Monitoring & Promotion Programme. Eur Heart J, 24: 1004–1013, 2003

    Article  PubMed  Google Scholar 

  • Klenk J, Nagel G, Ulmer H, Strasak A, Concin H, Diem G, Rapp K; the VHM&PP Study Group. Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol, 24: 83–91, 2009

    Article  PubMed  Google Scholar 

  • Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds.). Cancer incidence in five continents, vol. VIII. IARC Scientific Publication No. 155, Lyon, 2002

  • Oberaigner W, Vittadello F. Cancer mapping in Alpine regions 1996–2000. Pro Literatur Verlag, Mammendorf, 2006

  • Stocks T, Rapp K, Bjørge T, Manjer J, Ulmer H, Selmer R, Lukanova A, Johansen D, Concin H, Tretli S, Hallmans G, Jonsson H, Stattin P. Blood glucose and risk of incident and fatal cancer in the Metabolic syndrome and Cancer project (Me-Can): analysis of six prospective cohorts. PLoS Med, 6(12): e1000201, 2009. doi:10.1371/journal.pmed.1000201

  • Bjørge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, Rapp K, Ulmer H, Almquist M, Concin H, Hallmans G, Jonsson H, Stattin P, Engeland A. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol, 171: 892–902, 2010

    Article  PubMed  Google Scholar 

  • Häggström C, Stocks T, Rapp K, Bjørge T, Lindkvist B, Concin H, Engeland A, Manjer J, Ulmer H, Selmer R, Tretli S, Hallmans G, Jonsson H, Stattin P. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the Metabolic syndrome and Cancer project (Me-Can). Int J Cancer, 2010. doi:10.1002/ijc.25521

  • Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Häggström C, Stattin P, Engeland A. Metabolic syndrome and breast cancer in the Me-Can (Metabolic syndrome and Cancer) project. Cancer Epidemiol Biomarkers Prev, 19: 1737–1745, 2010

    Article  PubMed  Google Scholar 

  • Stocks T, Borena W, Strohmaier S, Bjørge T, Manjer J, Engeland A, Johansen D, Selmer R, Hallmans G, Rapp K, Concin H, Jonsson H, Ulmer H, Stattin P. Cohort profile: the Metabolic syndrome and Cancer project (Me-Can). Int J Epidemiol, 39: 660–667, 2010

    Article  PubMed  Google Scholar 

  • Johansen D, Stocks T, Jonsson H, Lindkvist B, Bjørge T, Concin H, Almquist M, Häggström C, Engeland A, Ulmer H, Hallmans G, Selmer R, Nagel G, Tretli S, Stattin P, Manjer J. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic syndrome and Cancer project. Cancer Epidemiol Biomarkers Prev, 19: 2307–2317, 2010

    Article  PubMed  CAS  Google Scholar 

  • Nagel G, Concin H, Bjørge T, Rapp K, Manjer J, Hallmans G, Diem G, Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stocks T, Tretli S, Ulmer H, Stattin P, Lukanova A. Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can). Ann Oncol, 2010 [Epub ahead of print]

  • Stocks T, Lukanova A, Bjørge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel G, Tretli S, Veierød MB, Jonsson H, Stattin P. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the Metabolic syndrome Cancer project (Me-Can). Cancer [Epub ahead of print], 2010

  • Borena W, Stocks T, Jonsson H, Strohmaier S, Nagel G, Bjørge T, Manjer J, Hallmans G, Selmer R, Almquist M, Häggström C, Engeland A, Tretli S, Concin H, Strasak A, Stattin P, Ulmer H. Serum triglycerides and cancer risk in the metabolic syndrome and Cancer (Me-Can) collaborative study. Cancer Causes Control, 2010. doi:10.1007/s10552-010-9697-0

  • Edlinger M, Strohmaier S, Jonsson H, Bjørge T, Manjer J, Borena WT, Häggström C, Engeland A, Tretli S, Concin H, Nagel G, Selmer R, Johansen D, Stocks T, Hallmans G, Stattin P, Ulmer H. Metabolic syndrome and risk of brain tumour in the large population-based Me-Can cohort study. 2010. [Submitted]

  • Borena W, Strohmaier S, Lukanova A, Jonsson H, Lindkvist B, Bjørge T, Edlinger M, Stocks T, Nagel G, Manjer J, Engeland A, Selmer R, Häggström C, Tretli S, Concin H, Hallmans G, Stattin P, Ulmer H. Metabolic risk factors and primary liver cancer in a large prospective study of 578,700 adults. 2010. [Submitted]

  • Strasak AM, Rapp K, Hilbe W, Oberaigner W, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H; the VHM&PP Study Group. Serum uric acid and risk of cancer mortality in a large prospective male cohort. Cancer Causes Control, 18: 1021–1029, 2007

    Article  PubMed  Google Scholar 

  • Strasak AM, Rapp K, Hilbe W, Oberaigner W, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H, on behalf of the VHM&PP Study Group. The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28,000 older Austrian women. Ann Oncol, 18: 1893–1897, 2007

    Article  PubMed  CAS  Google Scholar 

  • Strasak AM, Lang S, Kneib T, Brant LJ, Klenk J, Hilbe W, Oberaigner W, Ruttmann E, Kaltenbach L, Concin H, Diem G, Pfeiffer KP, Ulmer H; the VHM&PP Study Group. Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78,850 men. Ann Epidemiol, 19: 15–24, 2009

    Article  PubMed  Google Scholar 

  • Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, Oberaigner W, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H; the VHM&PP Study Group. Association of γ-Glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res, 68: 3970–3977, 2008

    Article  PubMed  CAS  Google Scholar 

  • Strasak AM, Pfeiffer RM, Klenk J, Hilbe W, Oberaigner W, Gregory M, Concin H, Diem G, Pfeiffer KP, Ruttmann E, Ulmer H; the VHM&PP Study Group. Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. Int J Cancer, 123: 1902–1906, 2008

    Article  PubMed  CAS  Google Scholar 

  • Strasak AM, Goebel G, Concin H, Pfeiffer RM, Brant LJ, Nagel G, Oberaigner W, Concin N, Diem G, Ruttmann E, Gruber-Moesenbacher U, Offner F, Pompella A, Pfeiffer KP, Ulmer H; the VHM&PP Study Group. Prospective study of the association of serum γ-Glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer. Cancer Res, 70: 3586–3593, 2010

    Article  PubMed  CAS  Google Scholar 

  • Fentiman IS, Allen DS. γ-Glutamyl transferase and breast cancer risk. Br J Cancer, 103: 90–93, 2010

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, Innsbruck, Austria

    M. Edlinger, Alexander M. Strasak & H. Ulmer

  2. Institute of Epidemiology, Ulm University, Ulm, Germany

    G. Nagel

  3. Department of Haematology and Oncology, Innsbruck Medical University, Innsbruck, Austria

    W. Hilbe

  4. Agency for Preventive and Social Medicine, Bregenz, Austria

    G. Diem & H. Concin

Authors
  1. M. Edlinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Nagel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Hilbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Diem
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Concin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alexander M. Strasak
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Ulmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Edlinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edlinger, M., Nagel, G., Hilbe, W. et al. Associations of serum uric acid and gamma-glutamyltransferase with cancer in the Vorarlberg Health Monitoring and Promotion Programme (VHM&PP) – a short review. memo 4, 50–54 (2011). https://doi.org/10.1007/s12254-011-0249-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-011-0249-4

Keywords

Search

Navigation